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Introduction
Nuclear protein import is dependent on NLSs, which are recog-
nized by members of the importin (IMP) superfamily of nuclear 
transport receptors (Poon and Jans, 2005). The best character-
ized pathway involves the recognition of an NLS-containing 
cargo by IMP1 directly or the IMP/1 heterodimer, where 
IMP is an adaptor protein (Cingolani et al., 2002; Poon and 
Jans, 2005). In the absence of IMP1, IMP is “autoinhibited” 
through an intrinsic NLS within IMP’s IMP-binding (IBB) 
domain, which binds to its NLS binding site (Kobe, 1999; 
Harreman et al., 2003a,b; Goldfarb et al., 2004). Binding of IMP1 
to the IBB domain relieves IMP autoinhibition to permit acces-
sibility to the NLS binding site (Cingolani et al., 1999; Kobe, 
1999; Conti and Kuriyan, 2000; Goldfarb et al., 2004). IMP1 
subsequently mediates passage of the IMP/ heterodimer–
cargo complex through the nuclear envelope–embedded nuclear 
pore, before dissociation of the complex in the nucleus upon 
binding to IMP1 of the monomeric guanine nucleotide bind-
ing protein Ran in activated GTP-bound form (Poon and 
Jans, 2005).
Mechanisms of regulation of nuclear protein import, 
central to signal transduction/transcriptional outcomes in the 
nucleus, include those mediated by a specialized class of diverse 
cytoplasmic proteins, negative regulators of nuclear import 
(NRNIs), which sequester molecules in the cytoplasm to prevent 
their nuclear import. Cytoplasmic retention of the NLS-containing 
transcription factors NF-B and Gli1, for example, is effected 
by specific NRNIs, such as inhibitor of B (IB) and sup-
pressor of fused (Su(fu)), respectively, which prevent IMP rec-
ognition by NLS masking (Jacobs and Harrison, 1998; Ding 
et al., 1999; Bergqvist et al., 2006). Analogously, the BRCA1-
binding protein BRAP2 (Li et al., 1998) can negatively regu-
late the nuclear import of different cellular and viral proteins, 
dependent on phosphorylation flanking the NLS (Fulcher et al., 
2010). Finally, a truncated form of IMP2 (“CanRch1”) from 
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Figure 1. Ei24 coprecipitates and colocalizes with specific IMPs and shares homology with the IBB domain of IMP2. (A) FLAG-Ei24 expressed in 
HEK293T cells was immunoprecipitated using anti-FLAG (lane 1) or anti-Ei24 (lane 2) antibodies. Bound proteins were separated by SDS-PAGE, transferred 
to a nylon membrane, stained with a Sypro Ruby dye, and subsequently analyzed by MALDI-TOF MS. Bands identified as IMP1, IMP7, and Ei24 are 
indicated (see Table S1 for details). (B) Endogenous Ei24 or IgG immunoprecipitates (IP)/input lysates from HEK293T cells were resolved by SDS-PAGE 
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a human breast cancer line has been reported to inhibit nuclear 
accumulation of the tumor suppressor p53 (Kim et al., 2000).
Here, we describe the ability of the etoposide-induced 
protein Ei24 (etoposide-induced mRNA 2.4 kb) to act as an 
NRNI for the first time. Ei24 is an ER-localized protein (Zhao 
et al., 2005, 2012) originally identified as a p53-induced pro-
apoptotic gene in etoposide-treated NIH3T3 cells (Lehar et al., 
1996). It has been shown to be able to bind to the antiapoptotic 
protein Bcl-2 (Zhao et al., 2005), play a role in autophagy (Tian 
et al., 2010; Zhao et al., 2012), and induce growth arrest/apop-
tosis (Gu et al., 2000), but very little is known about how Ei24 
may mediate these diverse functions. To address this, we used 
a nonbiased proteomics approach, identifying members of the 
IMP superfamily as binding partners of Ei24. We show that 
Ei24 contains an “IBB-like” (IBBL) domain conferring strong 
interaction with IMP2 and IMP1 in a similar fashion to the 
IBB of IMP2. We also show that Ei24 is able to reduce the 
nuclear accumulation of IMP/1- and IMP1-dependent car-
goes, dependent on key basic residues within the IBBL domain; 
induction of endogenous Ei24 expression through etoposide 
treatment has the same effect. Collectively, the findings indicate 
that Ei24 is a novel IBBL-containing NRNI, shedding new light 
on Ei24’s various cellular functions.
Results and discussion
Ei24 interacts with specific IMPs and 
shares homology with IMP2
Previous studies have implicated Ei24 in growth arrest, apoptosis, 
and autophagy (Polyak et al., 1997; Gu et al., 2000; Zhao et al., 
2005, 2012; Tian et al., 2010). We applied a nonbiased proteomics 
approach to identify potential interacting proteins of Ei24 from 
human embryonic kidney HEK293T cells transfected to express 
FLAG-tagged Ei24 (FLAG-Ei24), subjected to immunoprecipi-
tation (IP) using anti-FLAG or -Ei24 antibodies (Fig. 1 A) with 
preimmune serum as a control (Fig. S1 A). Mass spectrometric 
analysis identified Ei24, as well as several other proteins enriched 
in the anti-FLAG and -Ei24 immunoprecipitates, including the 
IMP superfamily members IMP1 and Ran-binding protein 7 
(IMP7; Fig. 1 A and Table S1). CoIP of endogenous Ei24 under 
high stringency conditions followed by Western analysis using 
specific antibodies confirmed that IMP1, IMP2, and IMP7, but 
not IMP2 or IMP4, were complexed to Ei24 under physiologi-
cal conditions (Fig. 1 B and not depicted).
Perusal of the human and mouse Ei24 sequence revealed 
a conserved, basic 51–amino acid region (Fig. 1 C) with 33% 
similarity to IMP2’s IBB, a highly basic domain that is rec-
ognized specifically by IMP1 to facilitate formation of the 
IMP/1 heterodimer (Cingolani et al., 1999). We named this 
the IBBL domain of Ei24, and first tested whether it can confer 
binding to IMP1 and/or IMP2 in a similar fashion to the IBB 
of IMP. Consistent with this idea, endogenous Ei24 was found 
to colocalize with IMP1, IMP2, and IMP7, particularly in 
the perinuclear region of HeLa cells treated with etoposide to 
up-regulate Ei24 expression (Fig. 1 D; see Fig. S1, C and D, 
indicating a significant approximately twofold increase in the 
extent of colocalization, concentrated to a marked extent at the 
ER). Importantly, proteinase K digestion of preparations of ER 
from subcellular fractionation experiments of cells expressing 
N-terminally FLAG-tagged Ei24 indicated that the IBBL was 
exposed to the cytosol (Fig. S1 B), which is consistent with the 
idea that Ei24–IMP interaction in the cytoplasm/at the ER may 
occur under normal physiological conditions.
RanGTP can effect IMP1-dependent 
dissociation from Ei24
After IMP-mediated transport into the nucleus, binding of 
RanGTP to IMP1 dissociates the transport complex by displac-
ing IMP2’s IBB from IMP1 (Görlich et al., 1996b; Lee et al., 
2005). To test if RanGTP can release endogenous IMP1 from 
Ei24, GFP-tagged Ei24 (GFP-Ei24) was immunoprecipitated 
in the absence or presence of GTPS, a nonhydrolyzable form 
of GTP that maintains Ran in the GTP-bound state, followed 
by Western analysis and densitometry (Fig. 2, A and B). As 
expected, IMP2 was coprecipitated with the control protein 
GFP-IMP1 in the absence of GTPS, but to a significantly 
(P < 0.05) lower extent in its presence. Importantly, GTPS de-
creased GFP-Ei24 binding to IMP1 (P < 0.01); similar results 
were observed upon the addition of recombinant Ran loaded 
with GTPS but not GDP to lysates from cells expressing GFP-
Ei24 (Fig. 2 C). In contrast to the results for IMP1, pull-down 
of IMP2 by GFP-Ei24 was unaffected by GTPS (Fig. 2, 
A and B), whereas GFP-Ei24 did not coprecipitate other IMP 
homologues such as IMP2 or IMP13; GFP alone did not co-
precipitate any IMP, which implies that the observed interactions 
are specific. These results support the idea that RanGTP can 
inhibit Ei24–IMP1 binding, which is consistent with Ei24’s 
IBBL conferring interaction with IMP1 in an analogous fash-
ion to the IBB of IMP.
Ei24 binds to IMPs with high affinity
We next tested whether Ei24’s IBBL can bind directly to IMPs 
in vitro, comparing results to those of CanRch1, a form of 
IMP2 truncated at residue 89 that includes the IBB but not 
the NLS-binding domain (Kim et al., 2000). An AlphaScreen 
binding assay (Wagstaff and Jans, 2006) was performed using 
purified bacterially expressed His6-IMPs, biotinylated GST-
CanRch1 and -Ei24N (2–225 aa) proteins (Fig. 3 and Table 1).  
before Western analysis using the specific antibodies indicated. (C) Multiple sequence alignment of the human and mouse Ei24 IBBL domains (predicted 
to form an -helical structure using Protein Homology/Analogy Recognition Engine version 2.0) together with IMP2/CanRch1, performed as described in 
Materials and methods. Numbers indicate the portion of the amino acid residues (single letter code) within the respective proteins. Gray and black shading 
indicates similar and identical residues, respectively. Sites of targeted mutation in this study are indicated by asterisks. (D) HeLa cells treated with 50 µM 
etoposide or DMSO vehicle control for 16 h were fixed and immunostained using specific antibodies for endogenous IMP1, IMP2, IMP7, or Ei24, and 
counterstained with DAPI. Merged images are shown at higher magnification (high mag., bottom panels). Yellow coloration in merged images indicates 
colocalization; quantitative analysis is presented in Fig. S1, C and D. Bars, 20 µm.
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reduced (>80%) binding to both Ei24N and CanRch1 (Fig. 3), 
which indicates that the Ei24 IBBL requires the same resi-
dues on IMP1 for high-affinity binding as those interacting 
with the prototypical IBB. Ei24N and CanRch1 also bound to 
IMP2IBB (truncated form of IMP2 lacking the IBB) in 
near identical fashion to IMP1 in terms of both maximal bind-
ing and Kd (4 nM); binding to full-length (FL) IMP2 wild 
Ei24 2–225 corresponds to a clinically derived, breast cancer 
truncated form of Ei24 that lacks the C-terminal 133 residues 
but retains the IBBL (Gentile et al., 2001).
Ei24N resembled CanRch1 in binding to IMP1 with 
high affinity (5 nM); in contrast, a mutant of IMP1 unable 
to bind the IBB (“IBBm,” mutated at residues W430/W472/
W864; Koerner et al., 2003), showed significantly (P < 0.0001) 
Figure 2. IMP1 recognition by Ei24 is inhib-
ited in the presence of GTPS or recombinant 
RanGTP. (A) Lysates from HeLa-BclXL cells ex-
pressing GFP, GFP-Ei24, or GFP-IMP1 fusion 
proteins prepared 20 h after transfection were 
subjected to IP with GFP-Trap resin in the ab-
sence or presence of 1.7 mM GTPS. Western 
analysis was performed on input and immuno-
precipitates (IP: GFP) using the specific antibod-
ies indicated. (B) Densitometric analysis was 
performed on images such as those shown in 
A for binding of endogenous IMP1 (left) and 
IMP2 (right) to GFP-Ei24 or GFP-IMP1, as in-
dicated. Pooled results (n ≥ 2) representing the 
mean ± SD (error bars) for IMP bound relative 
to no GTPS treatment (No add.) are shown; 
p-values (Student’s t test) denote significant dif-
ferences. NS, not significant. (C) Lysates from 
HeLa-BclXL cells expressing GFP-Ei24 or GFP 
alone were incubated for 20 min with 3 µM re-
combinant of Ran loaded with GTPS or GDP, 
before IP and Western blot analysis as in A.
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IMP (Catimel et al., 2001), which is consistent with FL 
IMP’s documented autoinhibited state (Kobe, 1999; Harreman 
et al., 2003a,b; Goldfarb et al., 2004). The comparable Kd of 
7 nM for the Ei24 IBBL and CanRch1 binding to FL and 
IBB truncated IMP2 indicates that the binding site for the 
type (WT) was more than twofold lower (Fig. 3 and Table 1). 
These results concur with previous studies reporting a very 
similar Kd for binding of the IMP IBB to either IMP1 or 
IMP2IBB (Harreman et al., 2003a,b), as well as strongly re-
duced binding of the IBB to FL compared with IBB-deleted 
Figure 3. Like CanRch1, Ei24 can bind directly 
to IMP1 and IMPIBB with high affinity. 
(A) 30 nM of biotinylated (B)-GST-Ei24(N) or 
B-GST-CanRch1 was added to increasing con-
centrations of IMP1 (top), IMP2 (bottom), or 
their mutant derivatives, as indicated, and an 
AlphaScreen assay was performed (see Ma-
terials and methods). Results are for a single 
experiment (representative of three separate as-
says), with values calculated as the percentage 
of binding to IMP1 WT or IMP2IBB, with 
apparent dissociation constants (Kd) indicated. 
(B) Pooled data represent the mean percentage 
of maximal binding (±SEM, error bars; n ≥ 3) to 
Ei24N/CanRch1 for each IMP relative to that of 
IMP1 WT; p-values are shown for significant 
differences. IBBm, IBB-binding mutant.
Table 1. Binding affinities of Ei24N and CanRch1 to IMPs
B-GST protein His-IMP Kd Bmax
nM %
Ei24N IMP1 WT 5.1 ± 0.6 100 ± 0.06
IMP1 IBBm ND 24.0 ± 5.0 (P < 0.001)
IMP2 WT 7.3 ± 1.4 48.0 ± 5.8 (P < 0.001)
IMP2IBB 4.4 ± 2.2 101 ± 12
CanRch1 IMP1 WT 4.5 ± 0.5 100 ± 0.2
IMP1 IBBm ND 10.0 ± 2.5 (P < 0.001)
IMP2 WT 6.6 ± 3.5 48.4 ± 9.3 (P < 0.05)
IMP2IBB 9.6 ± 2.1 86.2 ± 7.0
Pooled data (n ≥ 3) from AlphaScreen assays performed as per Fig. 3 for the binding affinities (Kd) and maximal binding (Bmax) expressed as a percentage of Bmax 
relative to IMP1 for Ei24N and CanRch1, respectively. Results are for the mean ± SEM, with significant differences in maximal binding relative to IMP1 denoted 
by p-values. Harreman et al. (2003b) showed that binding of the IMP IBB to IMP1 and IMP2IBB is near identical in terms of Kd.
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p53 nuclear import is consistent with previous observations for 
CanRch1 (Kim et al., 2000), and implies that the C terminus/ 
ER localization of Ei24 is not essential for inhibition of p53 
nuclear import.
Ei24 is a general inhibitor of IMP1-  
and IMP2/1-mediated nuclear import
To test the ability of Ei24 to inhibit nuclear protein import gener-
ally, DsRed2-Ei24FL and DsRed2-Ei24N were coexpressed with 
constructs where GFP is fused to either the nuclear targeting sig-
nal of chicken anemia virus viral protein 3 (VP3; Wagstaff and 
Jans, 2006) or telomeric-repeat binding factor TRF1 (Forwood 
and Jans, 2002), both of which are dependent on IMP1 for nu-
clear import (Fig. 5, A and B; and Fig. S2). Results were com-
pared with those for DsRed2-CanRch1. Although GFP-VP3 was 
strongly nuclear when expressed alone, increased cytoplasmic 
fluorescence was evident in cells coexpressing DsRed2-tagged 
Ei24FL, Ei24N, or CanRch1 (Fig. 5 A), with quantitative analysis 
confirming a significant (P < 0.05) reduction (up to 30%) in 
the Fn/c (Fig. 5 B). A similar trend was observed for GFP-
TRF1, which indicates a significant (P < 0.001) decrease in the 
Fn/c in the presence of DsRed2-tagged Ei24FL, Ei24N, or Can-
Rch1, compared with in their absence (Fig. S2).
We also assessed the ability of Ei24 and CanRch1 to in-
hibit IMP/1-mediated nuclear import, observing a significant 
(P < 0.0001) up to 65% reduction in the Fn/c for GFP-p53 
upon ectopic expression of DsRed2-tagged Ei24FL, Ei24N, or 
CanRch1 compared with that of GFP-p53 expressed alone 
(Fig. 5, A and B), with similar results for the prototypical IMP/1-
recognized cargo GFP-T-ag NLS (Fig. S2). Overexpression of 
DsRed2-Ei24 or -CanRch1 did not affect nuclear accumulation 
of GFP-aF10 (Fig. 5, A and B). Collectively, the results indicate 
that the N terminus of Ei24 is sufficient to inhibit nuclear import 
specifically mediated by either IMP1 alone or IMP/1.
A polyarginine sequence within the IBBL 
domain is required for IMP1 binding and 
nuclear import inhibition
Harreman et al. (2003b) previously reported that mutations to 
the polybasic “RRRR” motif in the IMP IBB domain greatly 
reduce the affinity of binding to IMP1; this motif is present 
within the IBBL domain (RRRR62) from mouse and human 
Ei24 (Fig. 1 C). To test the contribution of these residues to 
Ei24 binding to IMP1, a FLAG-Ei24–encoding construct 
in which RRRR62 was mutated to alanine (RRRRm) was tested 
for its ability to bind IMP1 in HEK293T cells compared with 
that of the comparable WT construct. Whereas FLAG-Ei24 WT 
clearly interacted with endogenous IMP1, the mutant deriva-
tive RRRRm (Fig. 5 C) or derivative lacking the entire IBBL 
domain (not depicted) significantly (P < 0.0001) reduced the 
levels of immunoprecipitated IMP1, which indicates that 
the RRRR motif within the IBBL is required for Ei24 bind-
ing to IMP1. To assess the effect of the RRRRm mutation on 
Ei24’s ability to inhibit nuclear import, HeLa-BclXL cells were 
transfected to express GFP-p53, -VP3, or -aF10 together with 
FLAG-Ei24 WT or the mutant derivatives RRRRm or RKQ79 
(RKQm) as a control (Fig. 5, D and E). Nuclear accumulation of 
Ei24 IBBL is the NLS-binding site of IMP. IMP binding to 
GST alone was negligible (unpublished data), underlining the 
specificity of the interactions. All results were consistent with 
the idea that the Ei24 IBBL can bind directly to IMP1, in 
comparable fashion to the IMP IBB itself.
Endogenous Ei24 can inhibit p53  
nuclear import
To test the effect of high-affinity interaction of Ei24 with IMPs 
on IMP2/1-dependent nuclear import, a p53 WT and knock-
out (KO) murine embryonic fibroblast (MEF) system was used 
together with etoposide treatment (Liang and Clarke, 1999; 
Kim et al., 2000), which markedly up-regulates Ei24 expres-
sion in WT MEFs but not in MEFs lacking p53 (p53 KO; Fig. 4, 
A and B). GFP-p53 was expressed in DMSO or etoposide-
treated p53 WT and KO MEFs (Fig. 4 C), with GFP-aF10(696–
794 aa), the nuclear import of which is IMP independent 
(Cai et al., 2002), and GFP alone as controls. Quantitative analy-
sis to determine the nuclear-to-cytoplasmic fluorescence ratio 
(Fn/c) revealed that etoposide-treated WT MEFs significantly 
(P < 0.005) reduced (60%) the level of GFP-p53 nuclear ac-
cumulation compared with in its absence (Fig. 4 D); p53 KO 
MEFs showed no such effect. Notably, etoposide treatment 
of WT MEFs increased the number of GFP-p53 cytoplasmic 
aggregates compared with in its absence (Fig. 4 C), in con-
trast to KO MEFs, which showed few aggregates, implying 
that this localization may relate to Ei24 action. No aggregates 
were observed for the GFP-aF10 or GFP controls, which were 
unaffected by etoposide treatment (Fig. 4 D), underlining the 
specificity of the effect. p53-dependent up-regulation of Ei24 in 
response to etoposide can thus lead to inhibition of IMP/1-
mediated nuclear accumulation of GFP-p53, which implies that 
Ei24 may function in a negative feedback loop to contribute to 
dampening p53 activity in DNA damage (Lohrum et al., 2001; 
Nie et al., 2007). Reducing p53 nuclear access would in turn 
stem Ei24 up-regulation and initiate a return to steady state.
We also examined whether ectopically expressed Ei24 
could inhibit nuclear accumulation of endogenous p53 in 
HeLa-BclXL cells expressing DsRed2-Ei24 FL or DsRed2-
Ei24N, which, because it lacks the C-terminal portion of Ei24 
but retains the IBBL, does not localize strongly in the ER, in-
stead being largely nuclear (Fig. 4 E). This is consistent with 
the idea that like the IMP IBB, the IBBL can also function 
as a modular NLS (Görlich et al., 1996a; see also Fig. 5 A for 
DsRed2-CanRch1). Particular C-terminal sequences and/or the 
presence of all of the six transmembrane domains are presum-
ably necessary for Ei24 ER targeting, as is the case for other 
ER proteins (Sato et al., 1996; Honsho et al., 1998; Barré et al., 
2005). Cells were fixed 20 h after transfection and immuno-
stained for endogenous p53 or the heterogeneous nuclear ribo-
nucleoprotein hnRNPA1, whose nuclear transport is dependent 
on IMP2 (Nakielny et al., 1996; Fridell et al., 1997; Fig. 4 E). 
No significant effects on nuclear localization were observed for 
hnRNPA1, but both DsRed2-Ei24FL and -Ei24N significantly 
(P < 0.001) reduced p53 nuclear accumulation (up to 40%) 
compared with in their absence (Fig. 4 F). The fact that nuclear 
localized Ei24N retaining the IBBL was capable of inhibiting 
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Figure 4. Ei24 can inhibit nuclear translocation of p53. (A) Schematic of the experimental layout. (B) Western analysis of lysates from p53 WT and KO 
MEFs, treated with either 50 µM etoposide or DMSO vehicle control for 16 h, using an anti-Ei24 antibody with /-tubulin as a loading control. (C) Cells 
as in A were imaged live by CLSM 8 h after transfection. Cytoplasmic aggregates of GFP-p53 are indicated by yellow arrows. Bar, 20 µm. (D) Digitized 
images such as those in C were analyzed to calculate the nuclear-to-cytoplasmic fluorescence ratio (Fn/c; see Materials and methods). Results are for the 
mean ± SEM (error bars; n ≥ 34) from a single assay representative of three separate experiments. (E) HeLa-BclXL cells transfected to express DsRed2-fusion 
proteins, as indicated, were fixed 20 h after transfection before immunostaining using specific antibodies for endogenous p53 (top) or hnRNPA1 (bottom), 
and DAPI counterstaining. Bars, 20 µm. (F) Results from analysis such as that shown in E are for the mean ± SEM (error bars; n ≥ 65). P-values denote 
significant differences.
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Figure 5. Ei24 can inhibit IMP1- or IMP2/1-mediated nuclear accumulation dependent on a polyarginine sequence within its IBBL domain. (A) Live-cell 
CLSM images of HeLa-BclXL cells transfected to coexpress the indicated GFP and DsRed2 fusion proteins 20 h after transfection. Bars, 10 µm. (B) Quantita-
tive analysis for the extent of nuclear accumulation (Fn/c) of the various GFP fusion proteins. Results are for the mean ± SEM (error bars; n ≥ 41) from a 
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mammalian expression constructs prk5-FLAG-Ei24 (and mutant derivatives 
thereof), prk5-GFP-Ei24, prk5-DsRed2-Ei24, pEPI-GFP-p53, pEPI-GFP-VP3 
(residues 74–121), pEGFP-C1-T-ag NLS (residues 111–135), pEPI-GFP- 
TRF1 (residues 337–440), and pEPI-GFP-aF10 (residues 696–794), re-
spectively (Gu et al., 2000; Kuusisto et al., 2008, 2012; Wagstaff 
et al., 2012). The pGEX-6P vector plasmids, encoding Ran WT or the 
mutant derivative Q69L as GST fusion proteins under the control of the 
tac promoter (Tachibana et al., 2000; Ogawa et al., 2012), were sup-
plied by Y. Miyamoto (Monash University, Clayton, Australia). The 
N-terminal fragment of Rch1 (residues 2–89), corresponding to a human 
breast cancer line–derived mutation (Kim et al., 2000) referred to here 
as CanRch1, was cloned into the pDsRed2-C1 vector (Takara Bio Inc.) 
using BglII–BamHI sites to produce pDsRed2-C1-CanRch1. To generate 
pDsRed2-Ei24(2–225) (Ei24N), which corresponds to a truncation muta-
tion in Ei24 derived from a human breast cancer sample (Gentile et al., 
2001) and pDEST15-GST-CanRch1, the coding sequences of Ei24N (con-
taining residues 2–225) and CanRch1, respectively, were introduced into 
the Gateway system (Invitrogen) by PCR using attB site-containing prim-
ers and subsequent BP and LR recombination reactions. The integrity of 
all plasmid constructs was verified by DNA sequencing (Micromon DNA 
Sequencing Facility, Monash University).
Multiple sequence alignments for the Ei24 IBBL and IMP IBB domains
Multiple sequence alignment of the human and mouse Ei24 IBBL do-
mains together with the IBB domain from IMP2/CanRch1 was performed 
using ClustalW2 (European Molecular Biology Laboratory European 
Bioinformatics Institute) and BioEdit Sequence Alignment Editor version 
7.0.9.0. NCBI protein database accession numbers used for the alignment 
were: mEi24, Mus musculus Ei24 (NP_031941); hEi24, Homo sapiens 
Ei24 (NP_004870); M. musculus IMP2 (AAH03274); and H. sapiens 
Rch1 (EAL24416).
Cell culture and transfection
The HEK293T, HeLa, and HeLa-BclXL cell lines were all maintained in 
DMEM supplemented with 10% FCS, penicillin, and streptomycin in a hu-
midified incubator with 5% CO2 atmosphere at 37°C. HeLa-BclXL cells are 
resistant to apoptosis induced by Ei24 overexpression (Gu et al., 2000). 
Cells were transfected at 70–80% confluency using Lipofectamine 2000 
(Invitrogen) according to the manufacturer’s instructions.
Confocal laser scanning microscopy (CLSM)
Cells were imaged 16–20 h after transfection on an imaging system 
(Yokogawa CSU10 based CLSM system; Ultraview; PerkinElmer) with an 
EM charge-coupled device camera (Andor Technology) and a 100×/1.4 
NA oil immersion objective lens (Olympus) or an inverted CLSM system 
(C1 Inverted; Nikon) using a 100×/1.4 NA oil immersion objective lens 
(Nikon; Monash Micro Imaging). Cells were imaged in phenol red–free 
DMEM (Life Technologies), and live-cell imaging was routinely performed 
on a stage heated to 37°C. The Andor iQ and NIS-Elements version 4.10 
software was used for image acquisition on the Ultraview (PerkinElmer) 
and CLSM (C1 Inverted; Nikon) systems, respectively. Digitized images 
were subsequently analyzed using the ImageJ 1.33u software (National In-
stitutes of Health) to calculate the nuclear (Fn) to cytoplasmic (Fc) fluores-
cence ratio (Fn/c), corrected for by subtracting the background fluorescence (Fb). 
ImageJ software was also used to alter the brightness and contrast levels 
uniformly across all samples in the same assay to enhance visibility and for 
pseudocoloring where appropriate.
Indirect immunofluorescence
Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) 16–20 h after 
transfection and permeabilized using 0.2% Triton X-100 (Sigma-Aldrich) in 
blocking buffer (1% BSA in PBS). Non-specific binding sites were blocked 
with blocking buffer and immunostained with primary antibodies anti-Ei24 
(Ab35) at 1:100, anti-IMP1 (Abcam) at 1:500, anti-IMP2 (BD) at 1:200, 
the IMP1 nuclear import cargo GFP-VP3 was significantly 
(P < 0.05) reduced by Ei24 WT and the RKQm mutant, in stark 
contrast to coexpression with RRRRm. Comparably, there was 
a significant (up to 35%) decrease in the Fn/c of GFP-p53 in 
the presence of Ei24 WT (P < 0.001) and RKQm (P < 0.05), 
respectively, but not RRRRm, relative to GFP-p53 alone (Fig. 5, 
D and E). A similar trend was observed for the IMP/1- 
recognized cargo, GFP-T-ag NLS (Fig. S2). No effect of Ei24 
WT, RRRRm, or RKQm was detectable for nuclear accumula-
tion of GFP-aF10, which is consistent with the idea that Ei24 
inhibition of nuclear import is specific for IMP/1- and IMP1- 
dependent cargoes. Thus, Ei24’s conserved RRRR62 motif, but 
not RKQ79, is central to Ei24-dependent inhibition of nuclear 
import through specific binding to IMP1.
In summary, this is the first study to shed light on the func-
tion of the ER-localized p53-induced factor Ei24, showing that it 
possesses a novel IBBL domain that retains key properties of the 
prototypical IBB of IMP in terms of ability to bind to IMP1, 
as well as to IMP, through the same binding site as that used 
to bind the IBB. Instead of facilitating nuclear import, however, 
Ei24 inhibits IMP/1- and 1-dependent nuclear protein import 
by sequestering IMP1 and possibly IMP in the cytoplasm/at 
the ER. We postulate that there is a fine balance between IMP- 
dependent nuclear import and inhibition thereof by Ei24, enabling 
fine tuning of the nuclear import efficiency of important proteins 
such as p53 during normal cell function, as well as during stress 
such as DNA damage. Perturbation of the balance between these 
import pathways can clearly be effected by changes in expres-
sion of Ei24, as shown here (Fig. 1 D and Fig. 4). Relatively 
small changes in the cellular pool of IMP1 and possibly IMP 
can significantly impact the nuclear transport efficiency of key 
nuclear import cargoes as shown here, and in turn, presumably, 
autophagy/stress responses and/or apoptosis (Gu et al., 2000).
Increased nuclear IMP levels have been reported to cor-
relate with poor prognoses for patients with advanced breast 
cancer (Gluz et al., 2008), with nuclear import specifically en-
hanced in cancerous/transformed cells (Kuusisto et al., 2012). 
Clearly, deregulated IMP/1-mediated nuclear import is closely 
linked to tumorigenesis. The role of Ei24 in inhibiting IMP-
dependent nuclear protein import in this context may be abso-
lutely critical, as well as the basis of Ei24’s tumor suppressor 
properties, and is the focus of future work in this laboratory.
Materials and methods
Plasmid constructs
FLAG-Ei24 (and mutant derivatives thereof), GFP-Ei24, DsRed2-Ei24, 
GFP-p53, GFP-VP3, GFP-T-ag NLS, GFP-TRF1, and GFP-aF10 were ex-
pressed under the control of a cytomegalovirus (CMV) promoter encoded by 
single assay representative of three separate experiments; p-values denote significant differences. (C) Lysates from HEK293T cells transfected to express 
FLAG-Ei24 WT, RRRRm mutant derivative, or vector alone were subjected to immunoprecipitation using anti-FLAG M2 antibody. Western analysis was 
performed on input and immunoprecipitates (IP: FLAG) using specific antibodies against IMP1 or Ei24, with -actin as a control. Densitometric analysis 
was performed on images such as those shown in C; results are for the mean ± SEM (error bars n = 3) for binding (%) relative to that for WT. (D) CLSM 
images of HeLa-BclXL cells transfected to coexpress the indicated GFP fusion proteins in the absence or presence of FLAG-Ei24 derivatives were fixed 20 h 
after transfection before being immunostained using an anti-FLAG M2 antibody. Bars, 10 µm. (E) Quantitative analysis of the extent of nuclear accumula-
tion for the various GFP fusion proteins. Results shown are for the mean ± SEM (error bars; n ≥ 40) for a single assay representative of three independent 
experiments. Statistical analysis was performed as in B.
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10 times. Precleared lysate was added to 10 µg anti-Ei24 (Sigma-Aldrich) 
or rabbit IgG (Santa Cruz Biotechnology, Inc.) antibody and 50 µl Protein 
A/G plus agarose slurry (Santa Cruz Biotechnology, Inc.), and incubated 
overnight at 4°C. Immunoprecipitates were washed with RIPA buffer and 
eluted in 3× Laemmli sample buffer. HeLa-BclXL cells grown in 6-cm2 dishes 
expressing GFP-Ei24 or GFP-IMP1 fusion proteins were lysed with dilu-
tion buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.5 mM EDTA), 
0.5% NP-40 (Sigma-Aldrich), and Complete EDTA-free protease inhibitors 
(Roche). In some experiments, lysates were preincubated with a final con-
centration of 1.7 mM GTPS (Sigma-Aldrich) or 3 µM recombinant Ran re-
constituted with GTPS or GDP for 20 min on ice. Immunocomplexes were 
bound to and eluted from the GFP-Trap resin (ChromoTek) according to 
the manufacturer’s instructions. Protein from whole-cell extracts or immuno-
precipitates were resolved by SDS-PAGE and transferred to nitrocellulose 
membrane (Pall). Specific proteins were detected on membranes probed 
with anti-GFP (Roche) at 1:1,000, anti-IMP1 (provided by D. Görlich,, 
Max Planck Institute, Göttingen, Germany; or from Abcam) at 1:1,000, 
anti-IMP4 (KPNA3; Abcam) at 1:500, anti-IMP2 (BD) at 1:1,000, anti-
IMP2 (BD) at 1:500, anti-IMP13 (rabbit polyclonal antibody generated 
against the synthetic peptides LPEEFQTSRLPQYRKGLVR and EQKDTF-
SQQILRERVNKRRVK; Tao et al., 2006) at 1:1,000, anti-FLAG antibody 
(Sigma-Aldrich), or anti-BiP (Cell Signaling Technology), together with spe-
cies-specific HRP-conjugated secondary antibody (EMD Millipore). Protein 
bands were visualized using Western Lightning ECL reagent (PerkinElmer) 
and chemiluminescence detection on x-ray film (Fujifilm). Densitometric 
analysis of protein bands was performed on digitized images of immuno-
blots using the ImageJ 1.33u software (Kaur et al., 2013).
Mass spectrometry (MS)
Immunoprecipitated proteins transferred to nylon membranes were identi-
fied by Sypro Ruby Protein Gel Stain (Molecular Probes; Life Technologies), 
excised, reduced, and alkylated with iodoacetamide, and digested with 
trypsin. The unfractionated tryptic digest was subjected to MS using the 
4700 Proteomics Analyzer (Applied Biosystems), which employs matrix-
assisted laser desorption/ionization (MALDI) in conjunction with tandem 
time-of-flight (TOF) mass analyzers. The digest was introduced into the in-
strument in a crystalline matrix of -cyano-4-hydroxycinnamic acid. Database 
searches were performed with GPS Explorer software (Applied Biosystems), 
using the Mascot search engine (Perkins et al., 1999). Protein assignments 
were made based on both the MS and MS/MS spectra. Top-ranking pro-
teins that had a significant (P < 0.05) Mascot score from each band were 
identified (see Table S1 for detailed analyses). The protein scores were 
derived from ions scores as a nonprobabilistic basis for ranking protein 
hits. The Swiss-Prot database was used for protein identification.
Membrane topology analysis
Membrane topology for Ei24 was assessed using a modified method 
as described previously (Leighton and Schatz, 1995). In brief, cell pel-
lets from N-terminally FLAG-tagged Ei24 transfected HEK293 cells were 
washed with cold 1× PBS and resuspended in buffer A (10 µM NaCl, 
1.5 µM MgCl2, and 10 µM Tris, pH 7.5, containing complete proteinase 
inhibitor cocktail) for 1 h on ice. Cells were homogenized with a type B 
Dounce homogenizer until 80% of cells were lysed. An equal volume of 
buffer B (210 µM mannitol, 70 µM sucrose, 5 µM Tris, pH 7.5, and 1 µM 
EDTA, pH 7.5) was added immediately and the lysate was centrifuged at 
700 g for 10 min at 4°C to remove nuclei/intact cells. The supernatant was 
transferred into a new tube and then centrifuged at 1,200 g for 15 min 
at 4°C to isolate ER pellets, which were then resuspended in buffer B 
and aliquoted in 200-µg protein amounts. ER fractions were incubated 
for 30 min on ice in the presence or absence of 1 mg/ml proteinase K 
and inactivated using cold trichloroacetic acid. After centrifugation, the 
fractions were analyzed by Western blotting (as described earlier in the 
Materials and methods).
Online supplemental material
Fig. S1 (A and B) shows proteomic analysis of FLAG-Ei24 immuno-
precipitates with a preimmune antibody control and Ei24’s topology at 
the ER, with Table S1 showing MS analysis details. Fig. S1 (C and D) 
shows quantitative colocalization analysis of Ei24 and IMPs in etoposide-
treated HeLa cells. Fig. S2 demonstrates that Ei24 can inhibit IMP1- and 
IMP2/1-mediated nuclear translocation of GFP-TRF1 and -T-ag NLS, re-
spectively. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201304055/DC1.
anti-IMP7 (GeneTex) at 1:500, or anti-FLAG M2 (Sigma-Aldrich) at 1:200 
for 90 min, followed by a 60-min incubation with Alexa Fluor 488– or Alexa 
Fluor 568–conjugated secondary antibodies (Molecular Probes) at 1:1,000. 
Coverslips were mounted onto glass slides with 4% (wt/vol) propyl-gallate in 
90% glycerol (Sigma-Aldrich) or ProLong Gold antifade reagent with DAPI 
mounting media (Molecular Probes). Cells were imaged on the Ultraview or 
C1 Inverted CLSM systems using a 100×/1.4 NA oil immersion objective 
lens at room temperature. Digitized images were analyzed and processed 
using ImageJ software as described in the previous section.
Quantitative colocalization
Colocalization analysis was performed on digitized CLSM images using 
the ImageJ 1.33u software, where a defined Ei24 threshold signal above 
background levels (secondary antibody alone control) was overlaid onto 
that of the IMP signal to produce a merged image for colocalized Ei24 and 
IMP pixels. The pixel intensity of the merged image was expressed as a 
percentage of the total IMP signal to calculate the mean percentage of IMP 
colocalized with Ei24.
Protein expression, purification, and biotin labeling
GST-Ei24N (2–225 aa), GST-CanRch1, and GST-Ran (WT/Q69L; 
Tachibana et al., 2000; Ogawa et al., 2012) fusion proteins were ex-
pressed in Escherichia coli strain BL21(DE3) containing a pRARE2 plasmid. 
Cultures were grown to an OD600 of 0.6–1 and protein expression was 
induced with 0.1–1 mM IPTG for 6 h at 18°C. Pellets were lysed in 50 mM 
Tris, pH 8.0, 500 mM NaCl, 5 mg/ml lysozyme (Research Organics), and 
Complete EDTA-free protease inhibitors (Roche) before being sonicated 
three times for 30 s at 30-s intervals. Protein was purified from cleared 
lysate with equilibrated glutathione Sepharose 4B resin (GE Healthcare) 
and incubated at 4°C for 2 h, before elution with 10 mM of reduced gluta-
thione in 50 mM Tris, pH 8, and 500 mM NaCl. Glutathione was removed 
by dialysis and protein concentrated using a Centricon centrifugal filter unit 
with an appropriate molecular weight cutoff (Amicon; EMD Millipore). For 
AlphaScreen assays, recombinant GST fusion proteins were labeled using 
the EZ-Link Sulfo-NHS-LC-LC-Biotin reagent (Thermo Fisher Scientific), and 
free biotin was separated from labeled protein using a PD-10 Desalting 
Column (GE Healthcare), according to the manufacturer’s instructions. For 
the GST-Ran WT and GST-Ran(Q69L) proteins, GST was removed using 
PreScission Protease (GE Healthcare) according to manufacturer’s instruc-
tions, and the proteins then loaded with GDP or GTPS (Sigma-Aldrich), 
respectively, as described previously (Tachibana et al., 2000).
Hexa-histidine (His6)-tagged full-length IMP2 and IMPIBB (resi-
dues 67–503; Yang et al., 2010) were provided by S. Yang (Monash Uni-
versity). In brief, protein was expressed in E. coli strain BL21(DE3) grown 
to an OD600 of 1.0 and induced with 1 mM IPTG for 4 h at 28°C. Proteins 
were purified by affinity chromatography using nickel-nitrilotriacetic acid 
agarose (QIAGEN) and eluted in 500 mM imidazole. Dialysis was per-
formed to remove imidazole. His6-IMP1 WT and IBBm (containing muta-
tions W430A/W472A/W864A) proteins were expressed in the E. coli 
ER1003 strain and purification was performed on chitin beads followed 
by gel filtration on a Superose-12 column as described previously (Koerner 
et al., 2003).
AlphaScreen binding assay
The binding affinity of biotinylated GST-Ei24N, GST-CanRch1 or GST 
alone to His6-tagged IMPs was determined using the bead-based Alpha-
Screen assay (PerkinElmer), as described previously (Wagstaff and Jans, 
2006). In brief, 30 nM of biotinylated GST-Ei24N, GST-CanRch1, or GST 
alone was incubated with increasing concentrations of His6-tagged IMPs. 
After incubation with nickel-chelating acceptor and streptavidin-coated 
donor beads, results were read on a Fusion plate reader (PerkinElmer). 
Triplicate values were averaged and sigmoidal titration curves (three- 
parameter sigmoidal fit) were plotted using the SigmaPlot graphing pro-
gram (Systat Software Inc.) to determine the dissociation constant (Kd) and 
maximal binding (Bmax) value. It should be noted that the sensitivity of the 
AlphaScreen binding assay results in lower estimated Kd values than vari-
ous other assays (e.g., Catimel et al., 2001; Forwood and Jans, 2002; 
Harreman et al., 2003a,b; Fulcher et al., 2010), but relative/comparative 
values are comparable (e.g., see the legend for Table 1).
Immunoprecipitation and Western analysis
For IP of endogenous Ei24, HEK293T cells grown in 10-cm2 dishes were 
lysed in RIPA buffer (50 mM Tris-HCl, 100 mM NaCl, 2 mM EDTA, 
50 mM NaF, 0.4% sodium deoxycholate, 1% Triton X-100, and 1× Com-
plete EDTA-free protease inhibitors) and passed through a 26-gauge syringe 
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